Picture of Basilea Pharmaceutica AG, Allschwil logo

BSLN — Basilea Pharmaceutica AG, Allschwil News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Swiss stocks - Factors to watch on December 28

ZURICH/BERLIN, Dec 28 (Reuters) - Here are some of the
main factors that may affect Swiss stocks on Wednesday:
    COMPANY STATEMENTS
    Basilea Pharmaceutica  BSLN.S  said on Wednesday it had
fully repaid its 2.75% convertible bonds, which were due on
December 23, 2022, with an outstanding nominal amount of
113.8 million Swiss francs. 
    ECONOMY
    Swiss Investor Sentiment December due at 0900 GMT
 (Reporting by Zurich newsroom and Berlin Hub)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on Basilea Pharmaceutica AG, Allschwil

See all news